Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1973
Delayed Data
As of 3:58pm ET
 +0.0087 / +4.61%
Today’s Change
0.17
Today|||52-Week Range
0.40
-21.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-9.0M-17.4M-16.2M-17.5M
 
 
 
 
 
Depreciation630.0K683.0K691.0K1.1M
 
 
 
 
 
Total Other Cash Flow-2.0M1.3M1.5M457.0K
 
 
 
 
 
Funds From Operations-10.4M-15.4M-14.0M-15.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-268.0K-2.2M2.8M-1.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-10.1M-13.1M-16.8M-13.9M
 
 
 
 
 
 
InvestingIncrease In Investments-10.2M-32.8M0.000.00
 
 
 
Decrease In Investments20.9M22.7M23.5M3.2M
 
 
 
 
 
Capital Expenditures-1.8M-5.8M-898.0K-504.0K
 
 
 
 
 
Other Investing - Uses-4.0K0.00-71.0K0.00
 
 
 
Other Investing - Sources0.006.0K0.002.0K
 
 
 
Net Cash Flow Investing8.7M-16.1M22.3M2.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.005.4M0.000.00
 
 
Long Term Debt Reduction-71.0K-47.0K-7.1M-34.0K
 
 
 
 
 
Net Proceeds Stock Sale1.7M23.0M249.0K12.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.6M28.3M-6.8M12.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash183.0K-891.0K-1.4M1.4M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account